The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease

Background To determine whether baseline thyroid-stimulating immunoglobulin (TSI) bioassay or its early response upon treatment with an anti-thyroid drug (ATD) can predict prognosis of Graves’ disease (GD) in real-world practice. Methods This retrospective study enrolled GD patients who had previous...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jin Yu, Han-Sang Baek, Chaiho Jeong, Kwanhoon Jo, Jeongmin Lee, Jeonghoon Ha, Min Hee Kim, Jungmin Lee, Dong-Jun Lim
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Korean Endocrine Society 2023-06-01
coleção:	Endocrinology and Metabolism
Assuntos:	graves disease hyperthyroidism immunoglobulins, thyroid-stimulating thyrotropin-binding inhibitory immunoglobulin recurrence antithyroid agents
Acesso em linha:	http://www.e-enm.org/upload/pdf/enm-2023-1664.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!